Pasithea Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
MIAMI BEACH, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq:KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced that its Chief Executive Officer, Dr. Tiago Reis Marques, will deliver a virtual presentation at the H.C. Wainwright 24th Annual Global Investment Conference, being held from September 12-14, 2022 in New York, as follows:
Related news for (KTTA)
- Morning Market Recap: Precision Medicine Clears the Path, A&D Soars, and Gaming Gets a Buyback Boost
- From Spider Silk to Silk Roads: Microcaps Flex Real-World Momentum
- Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board
- Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025
- Today’s Top Performers: MoBot’s Market Review 05/20/25 07:00 AM